Novartis Ag (NVS) Gross Margin Growth (3y) (2012 - 2026)
Powered by 
Analysis
Novartis Ag (NVS) Gross Margin Growth (3y) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 650.65 Bn | 629.89 Bn | 17.26 Bn | -178.00 |
| 2 | AbbVie | 466.34 Bn | 459.82 Bn | 12.70 Bn | 532.00 |
| 3 | Merck | 362.11 Bn | 355.02 Bn | 12.21 Bn | 30.00 |
| 4 | Novartis Ag | 267.81 Bn | 260.52 Bn | 11.24 Bn | 455.00 |
| 5 | Pfizer | 157.31 Bn | 145.91 Bn | 10.94 Bn | -233.00 |
| 6 | Bristol Myers Squibb | 128.75 Bn | 117.69 Bn | 9.25 Bn | -310.00 |
| 7 | Sanofi | 51.80 Bn | 44.84 Bn | 10.79 Bn | 565.00 |
| 8 | Revolution Medicines | 40.91 Bn | 40.91 Bn | - | - |
| 9 | BeOne Medicines | 39.65 Bn | 34.55 Bn | 1.53 Bn | 589.00 |
| 10 | Incyte | 25.18 Bn | 20.65 Bn | 1.57 Bn | 89.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 455.00 |
| Mar 31, 2026 | 215.00 |
| Dec 31, 2025 | 455.00 |
| Sep 30, 2025 | 240.00 |
| Jun 30, 2025 | 890.00 |
| Mar 31, 2025 | 705.00 |
| Dec 31, 2024 | 602.00 |
| Sep 30, 2024 | 514.00 |
| Jun 30, 2024 | 512.00 |
| Mar 31, 2024 | 655.00 |
| Dec 31, 2023 | 207.00 |
| Sep 30, 2023 | 451.00 |
| Jun 30, 2023 | 127.00 |
| Mar 31, 2023 | 145.00 |
| Dec 31, 2022 | 539.00 |
| Sep 30, 2022 | 386.00 |
| Jun 30, 2022 | -23.00 |
| Mar 31, 2022 | -203.00 |
| Dec 31, 2021 | 277.00 |
| Sep 30, 2021 | 62.00 |